Los Angeles-based Cedars-Sinai has named Andrew Hendifar, MD, interim director of Cedars-Sinai Cancer.
Former interim director Robert Figlin, MD, was named associate dean of Cedars-Sinai Cancer Care, according to an Oct. 7 news release from the health system.
Dr. Hendifar currently serves as a professor of medicine, medical director of the Cancer Clinical Trials Office and medical director of the Gastrointestinal Oncology Disease Research Group at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute. He was a founding director of the hematology and oncology fellowship program and previously served as chief medical officer for the Pancreatic Cancer Action Network.
Dr. Figlin is the Steven Spielberg Family Chair in Hematology Oncology and a professor of medicine and biomedical sciences. He previously served as chair and associate director of the department of medical oncology and therapeutics research as well as associate director for clinical research at City of Hope Comprehensive Cancer Center in Duarte, Calif.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
